Skip to main content
NCBI home page
Journal of Psychiatry & Neuroscience: JPN logoLink to Journal of Psychiatry & Neuroscience: JPN
. 1994 Mar;19(2):109–113.

Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.

G Faludi 1, K Tekes 1, L Tóthfalusi 1
PMCID: PMC1188574  PMID: 8204562

Abstract

High affinity 3H-paroxetine and 3H-imipramine binding sites were simultaneously studied in platelets of 29 untreated patients with panic disorder and 12 healthy controls. The maximum number of binding sites (Bmax) was found to be significantly lower in the panic patients compared to the controls using either ligand. No difference in the Kd values between the groups of subjects was found. The disturbance of serotonin neurotransmission in panic disorder--decrease in Bmax values--may be either a consequence or a reason of serotonergic dysfunction.

Full text

PDF
109

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biessen E. A., Norder J. A., Horn A. S., Robillard G. T. Evidence for the existence of at least two different binding sites for 5HT-reuptake inhibitors within the 5HT-reuptake system from human platelets. Biochem Pharmacol. 1988 Oct 15;37(20):3959–3966. doi: 10.1016/0006-2952(88)90080-9. [DOI] [PubMed] [Google Scholar]
  2. Bäckström I. T., Marcusson J. O. 5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. I. Characteristics. Brain Res. 1987 Nov 3;425(1):128–136. doi: 10.1016/0006-8993(87)90491-4. [DOI] [PubMed] [Google Scholar]
  3. Bäckström I., Bergström M., Marcusson J. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue. Brain Res. 1989 May 8;486(2):261–268. doi: 10.1016/0006-8993(89)90511-8. [DOI] [PubMed] [Google Scholar]
  4. Bénavidès J., Savaki H. E., Malgouris C., Laplace C., Margelidon C., Daniel M., Courteix J., Uzan A., Guérémy C., Le Fur G. Quantitative autoradiography of [3H]indalpine binding sites in the rat brain: I. Pharmacological characterization. J Neurochem. 1985 Aug;45(2):514–520. doi: 10.1111/j.1471-4159.1985.tb04018.x. [DOI] [PubMed] [Google Scholar]
  5. Coplan J. D., Gorman J. M., Klein D. F. Serotonin related functions in panic-anxiety: a critical overview. Neuropsychopharmacology. 1992 May;6(3):189–200. [PubMed] [Google Scholar]
  6. D'Amato R. J., Largent B. L., Snowman A. M., Snyder S. H. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine. J Pharmacol Exp Ther. 1987 Jul;242(1):364–371. [PubMed] [Google Scholar]
  7. D'haenen H., De Waele M., Leysen J. E. Platelet 3H-paroxetine binding in depressed patients. Psychiatry Res. 1988 Oct;26(1):11–17. doi: 10.1016/0165-1781(88)90082-0. [DOI] [PubMed] [Google Scholar]
  8. Demushkin V. P., Fomenko A. M., Plyashkevich Y. G., Shchurin M. R., Brusov O. S. High- and low-affinity [3H]imipramine binding sites on human platelets: separate determination and involvement of sulphur-containing bonds. Eur J Pharmacol. 1987 Aug 11;140(2):171–178. doi: 10.1016/0014-2999(87)90802-8. [DOI] [PubMed] [Google Scholar]
  9. Hrdina P. D. Differentiation of two components of specific [3H]imipramine binding in rat brain. Eur J Pharmacol. 1984 Jul 20;102(3-4):481–488. doi: 10.1016/0014-2999(84)90569-7. [DOI] [PubMed] [Google Scholar]
  10. Hrdina P. D. Imipramine binding sites in brain and platelets: role in affective disorders. Int J Clin Pharmacol Res. 1989;9(2):119–122. [PubMed] [Google Scholar]
  11. Innis R. B., Charney D. S., Heninger G. R. Differential 3H-imipramine platelet binding in patients with panic disorder and depression. Psychiatry Res. 1987 May;21(1):33–41. doi: 10.1016/0165-1781(87)90059-x. [DOI] [PubMed] [Google Scholar]
  12. Klompenhouwer J. L., Fekkes D., van Hulst A. M., Moleman P., Pepplinkhuizen L., Mulder P. G. Seasonal variations in binding of 3H-paroxetine to blood platelets in healthy volunteers: indications for a gender difference. Biol Psychiatry. 1990 Sep 15;28(6):509–517. doi: 10.1016/0006-3223(90)90484-j. [DOI] [PubMed] [Google Scholar]
  13. Lewis D. A., Noyes R., Jr, Coryell W., Clancy J. Tritiated imipramine binding to platelets is decreased in patients with agoraphobia. Psychiatry Res. 1985 Sep;16(1):1–9. doi: 10.1016/0165-1781(85)90022-8. [DOI] [PubMed] [Google Scholar]
  14. Marazziti D., Rotondo A., Placidi G. F., Perugi G., Cassano G. B., Pacifici G. M. Imipramine binding in platelets of patients with panic disorder. Pharmacopsychiatry. 1988 Jan;21(1):47–49. doi: 10.1055/s-2007-1014646. [DOI] [PubMed] [Google Scholar]
  15. Marcusson J., Tiger G. [3H]imipramine binding of protein nature in human platelets: inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors. J Neurochem. 1988 Apr;50(4):1032–1036. doi: 10.1111/j.1471-4159.1988.tb10569.x. [DOI] [PubMed] [Google Scholar]
  16. Mellerup E. T., Plenge P., Engelstoft M. High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes. Eur J Pharmacol. 1983 Dec 23;96(3-4):303–309. doi: 10.1016/0014-2999(83)90321-7. [DOI] [PubMed] [Google Scholar]
  17. Mellerup E. T., Plenge P. High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes. Psychopharmacology (Berl) 1986;89(4):436–439. doi: 10.1007/BF02412117. [DOI] [PubMed] [Google Scholar]
  18. Mellerup E. T., Plenge P., Nielsen M. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes. Eur J Pharmacol. 1984 Nov 13;106(2):411–413. doi: 10.1016/0014-2999(84)90730-1. [DOI] [PubMed] [Google Scholar]
  19. Nutt D. J., Fraser S. Platelet binding studies in panic disorder. J Affect Disord. 1987 Jan-Feb;12(1):7–11. doi: 10.1016/0165-0327(87)90055-3. [DOI] [PubMed] [Google Scholar]
  20. Peterson G. L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem. 1977 Dec;83(2):346–356. doi: 10.1016/0003-2697(77)90043-4. [DOI] [PubMed] [Google Scholar]
  21. Plenge P., Mellerup E. T., Rafaelsen O. J. Chlorimipramine--but not imipramine--rapidly reduces imipramine--but not paroxetine--binding in human platelets. Clin Neuropharmacol. 1986;9 (Suppl 4):113–115. [PubMed] [Google Scholar]
  22. Pletscher A. Platelets as models: use and limitations. Experientia. 1988 Feb 15;44(2):152–155. doi: 10.1007/BF01952200. [DOI] [PubMed] [Google Scholar]
  23. Raisman R., Cash R., Agid Y. Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen. Neurology. 1986 Apr;36(4):556–560. doi: 10.1212/wnl.36.4.556. [DOI] [PubMed] [Google Scholar]
  24. Schneider L. S., Munjack D., Severson J. A., Palmer R. Platelet [3H]imipramine binding in generalized anxiety disorder, panic disorder, and agoraphobia with panic attacks. Biol Psychiatry. 1987 Jan;22(1):59–66. doi: 10.1016/0006-3223(87)90130-2. [DOI] [PubMed] [Google Scholar]
  25. Segonzac A., Schoemaker H., Langer S. Z. Temperature dependence of drug interaction with the platelet 5-hydroxytryptamine transporter: a clue to the imipramine selectivity paradox. J Neurochem. 1987 Feb;48(2):331–339. doi: 10.1111/j.1471-4159.1987.tb04098.x. [DOI] [PubMed] [Google Scholar]
  26. Uhde T. W., Berrettini W. H., Roy-Byrne P. P., Boulenger J. P., Post R. M. Platelet [3H]imipramine binding in patients with panic disorder. Biol Psychiatry. 1987 Jan;22(1):52–58. doi: 10.1016/0006-3223(87)90129-6. [DOI] [PubMed] [Google Scholar]
  27. Weizman A., Carel C., Tyano S., Rehavi M. Decreased high affinity 3H-imipramine binding in platelets of enuretic children and adolescents. Psychiatry Res. 1985 Jan;14(1):39–46. doi: 10.1016/0165-1781(85)90087-3. [DOI] [PubMed] [Google Scholar]
  28. Weizman A., Carmi M., Hermesh H., Shahar A., Apter A., Tyano S., Rehavi M. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients. Am J Psychiatry. 1986 Mar;143(3):335–339. doi: 10.1176/ajp.143.3.335. [DOI] [PubMed] [Google Scholar]
  29. Weizman R., Carmi M., Tyano S., Apter A., Rehavi M. High affinity [3H]imipramine binding and serotonin uptake to platelets of adolescent females suffering from anorexia nervosa. Life Sci. 1986 Mar 31;38(13):1235–1242. doi: 10.1016/0024-3205(86)90179-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Psychiatry and Neuroscience are provided here courtesy of Canadian Science Publishing

RESOURCES